• MORE MARKET STATS

E Kumar Sharma

Articles By E Kumar Sharma

80 Articles

Don’t blame the Kerala model, reinforce it & ramp up vaccination, says expert

Here's what eminent virologist Dr Gagandeep Kang has to say about Kerala's handling of the COVID-19 pandemic.

kerala handling of covid-29, gagandeep kang, virologist kang, kerala covid cases, Mortality & serosurvey data, Kerala covid vaccination

In times of crisis, the Centre must support the states: Dr Y V Reddy

Former governor of the Reserve Bank of India, an accomplished civil servant and the author of several books Dr Y V Reddy shares his views on the Indian federal structure, its design, the changing landscape and the new compuls

RBI Former Reserve Bank of India Governor YV Reddy (Reuters)

Biological E to make up to 100m Corbevax vaccine doses a month, seeks nod for studies on children

Mahima Datla, managing director of Biological E. Limited, outlines the status of her company's Covid vaccine development, supply commitments, and pricing in this exclusive interview.

Mahima Datla, Corbevax vaccine

New case surges a global worry but India must still aim to prevent a third wave, says WHO’s Dr Swaminathan

Financial Express Online reached out to Dr Swaminathan on where we stand on the still unfolding pandemic and what India needs to be focussed on having just emerged out of debilitating second wave and with fears of a likely th

World Health Organisation (WHO)’s chief scientist Dr Soumya Swaminathan

India’s new Ministry of Cooperation: What it delivers matters more than its birth

When it was announced that veteran politician Amit Shah would head the ministry there were both expectations and misgivings depending on who one spoke to.

Amit Shah Ministry of Cooperation

It’s time India’s drug controller confronts key questions on quality control & enforcement

From fake vaccination camps, spurious Covid-19 drugs (favipiravir tablets, amphotericin B vials for instance) to adverse events during clinical trials for vaccines, poor quality of testing kits and many more. These needed a f

covid 19 drugs

If we do not attract a third wave, there is hope for 9 % GDP growth in 2021-22: Dr Rangarajan

In terms of the recovery in the economic growth, Dr Rangarajan feels not much can be expected from the first quarter of this year since nearly one month and a half was lost completely with focus completely on the huge spurt i

Covid-19: The enemy is down but battle readiness now calls for more than ramp up in vaccinations

Experts have for long maintained that dampening the viral wave is best achieved only with aggressive inoculation drive.

covid

Why India’s children’s vaccination stats depend on which report you read

Here’s why some reports paint a different picture with one even showcasing child immunisation coverage far greater than the 60 per cent figure in 2014 that Prime Minister Narendra Modi referred to in his speech.

covid 19 vaccination for children

Concerns remain as GDP data only an economy snapshot before COVID-19 second wave struck

The economy grew by 1.6 per cent in the quarter and though the year saw an overall contraction of 7.3 per cent many experts were fearing worse and were therefore somewhat relieved.

india GDP, indian economy

Instadapp: How two Indian brothers in their 20s put a blockchain startup on the world map

On their business model and as to how they earn revenue, Sowmay Jain says: “Instadapp’s revenue model will be to deduct fees on financial volumes and lending/borrowing happening through the platform.”

Come Sept, India set to redefine online payments ecosystem with global tech giants; local players in the race

The key attraction for most is also apparently that it is to be incorporated as a company in India under the Companies Act, 2013 and likely to be allowed as a ‘for-profit’ entity.

Companies Act, 2013, redefine online payments ecosystem, Cholamandalam Investment and Finance Company, Murugappa Group, new umbrella entity, Kishore Biyani

Novo Nordisk to launch GLP-1 injectible diabetes drug in tablet form by February

The oral medication is being seen as a breakthrough technology that could change the approach and acceptance of the drug for patients in India, which today has the dubious distinction of being the diabetes capital of the worl

Novo Nordisk, GLP-1 injectible diabetes drug , weight reduction and reduced cardiac risk, oral medication, non-insulin treatment approach

Covid-19 is a global menace but why is mucormycosis more rampant in India?

Doctors describe it as a serious but somewhat rare fungal infection that is caused by a group of fungi called mucormycetes.

mucormycosis

Expect Covid-19 containment from August but serious work ahead, says Global expert Bhramar Mukherjee

Professor of Epidemiology and Biostatistics, School of Public Health at the University of Michigan, she believes it is when we notice the upticks in the virus that we really need to get more vigilant as it is only when we are

covid 19

India may soon allow Covid-19 jab for pregnant women, but where are the vaccine stocks?

Financial Express Online has reliably learnt from official sources that there is a thought process in favour of vaccinating pregnant and lactating women.

covid19 pregnant women

John Hopkins expert Dr Amita Gupta on India’s covid-19 challenge & future preparedness options

In an exclusive interview, Dr Amita Gupta, professor of Infectious Diseases at the John Hopkins School of Medicine and the co-director of the recently launched John Hopkins India Institute talks of the role that targeted lock

covid-19 second wave, coronavirus in India, John Hopkins School of Medicine, interview of Dr Amita Gupta, covid-19 & India’s future preparedness options, covid expected third wave,

Vaccine stocks down, vaccination rate falling: Where is the road map on the inoculation drive?

On Thursday, 6 May, the Indian government announced that since the start of the vaccination drive, the central government has provided over 171 million doses in all to the states and Union territories free of cost.

Looting of Covid-19 patients is a growing concern

Central to it all is a titanic struggle between demand and supply for critical medicines, oxygen, ambulance services and even for sweet lime and coconut water with crafty middlemen making the most of it.

COVID crisis: What is holding back easing of norms stifling high-impact NGOs?

Images of C-17 Globemaster carrying aid and precious supplies have travelled faster on cyberspace and are beginning to crowd the social media.

covid pandemic in india, contribution of high impact NGOs, C-17 Globemaster , Easing norms of NGOs, aid from Indian corporates, procuringa and supplying oxygen concentrators, cylinders, ventilators, Rapid Rural Community Response, sewa Mandir, CDDEP

Covid-19: Vaccinations for 18-44 age group begin in select states as hospitals have limited stocks

It is also learnt that some hospitals have huge capacities to dish out vaccines though the limitations can only be the availability of doses.

With COVID-19 cases rising, what can those with comorbidities do to stay safe?

Diabetes is a chronic ailment and has to be managed lifelong and if properly monitored then apparently there is nothing to worry about, but then connect with the doctor and regular checkups are critical.

With COVID-19 cases rising, what can those with comorbidities do to stay safe?

Vaccine registration opens for all adults at 4 PM on Co-Win app: What to expect from May 1?

The vaccines are all also still under emergency use authorization and therefore clarity on their supplies is crucial.

This is apart from many unanswered questions on the issues around final pricing and actual share of supplies and the exact modalities to execute the expanded vaccination drive.

Molnupiravir approval sought to target early stage COVID-19 cases: Natco vice chairman

Natco Pharma’s involvement with Molnupiravir and its relation with the US pharma giant Merck (MSD), which is behind the development of this drug, is however not clear and also not spelt out in the note to the bourses.

coronavirus

Can cryptocurrency bulls provide relief to India’s COVID-19 crisis?

In a sense, as one expert who has looked at this subject closely but does not wish to be identified, says, “it is viewed as any venture capital (VC) or private equity (OE) supporting Covid cause but in this case, stands out

cryptocurrency

COVID-19: Can India salvage the situation? Here’s what it is doing

At a time when those who are involved with mathematical modelling of the COVID situation and giving projections of the likely peak that India can expect in May, there is a view that a lot could be done to save the situation.

One way, to check the sliding of the moderately sick into serious illness is by focusing on the role that oxygen concentrators or mini oxygen generators can play.

Why is Covaxin’s final safety and efficacy report coming only in June? Bharat Biotech clarifies

The Phase 3 study enrolled 25,800 participants between 18 and 98 years of age, including 10 percent over the age of 60, with analysis conducted 14 days post 2nd dose.

Covid-19 vaccine Covaxin
Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement